About this trial
This observational study aims to develop a predictive model for the occurrence of new-onset stress urinary incontinence (SUI) after pelvic organ prolapse (POP) repair surgery in women. The primary questions it seeks to answer are:
Which risk factors and anatomical characteristics predispose women to new-onset stress urinary incontinence following pelvic organ prolapse repair surgery?
Female POP patients without any preoperative symptoms of urinary incontinence will receive telephone follow-ups at 3, 6, and 12 months after undergoing standard surgical treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with pelvic organ prolapse quantification (POP-Q) stage II or higher;
Patients who require surgical treatment for pelvic organ prolapse;
Patients with no evidence of urinary incontinence before surgery.
Disqualifiers
Patients confirmed to have urinary incontinence before surgery;
Patients with urinary or reproductive system infections;
Patients with a history of prior surgery for urinary incontinence;
Patients who have undergone previous mesh repair surgery for pelvic organ prolapse;
Trial population
Patients who visited the outpatient clinic of Shanghai General Hospital for pelvic organ prolapse.
Trial design
Case-control
Prospective
Treatments tested in this trial
Telephone follow-up
Diagnostic testParticipants will be required to complete the PFDI-20 and ICI-Q-SF questionnaires verbally during telephone follow-ups. If postoperative de novo SUI is highly suspected, participants will be advised to attend an outpatient clinic for further evaluation, including a pelvic floor ultrasound examination.
Treatment groups
Trial outcomes
Primary outcomes
Pelvic floor ultrasound
Secondary outcomes
Pelvic Floor Distress Inventory-20 (PFDI-20)
International Consultation on Incontinence Questionnaire Short Form (ICI-Q-SF)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.